@article{Bedston_S-2023_164897,
title = {Risk of severe COVID-19 outcomes after autumn 2022 COVID-19 booster vaccinations: a pooled analysis of national prospective cohort studies involving 7.4 million adults in England, Northern Ireland, Scotland and Wales},
author = {Bedston, S. and Almaghrabi, F. and Patterson, L. and Agrawal, U. and Woolford, L. and Anand, S. and Joy, M. and Crawford, A. and Goudie, R. and Byford, R. and Abbasizanjani, H. and Smith, D. and Laidlaw, L. and Akbari, A. and Sullivan, C. and Bradley, D. and Lyons, R. and de Lusignan, S. and Hobbs, F. and Robertson, C. and Sheikh, A. and Shi, T.},
month = {dec},
year = {2023},
abstract = {BackgroundUK COVID-19 vaccination policy has evolved to offering COVID-19booster dosesto individuals at increased risk of severe Illness from COVID-19. Building on our analyses of vaccine effectiveness of first, second and initial booster doses, we aimed to identify individuals at increased risk of severe outcomes (i.e., COVID-19 related hospitalisation or death) post the autumn 2022 booster dose.},
volume = {37},
journal = {The Lancet Regional Health - Europe},
publisher = {Elsevier},
url = {https://doi.org/10.1016/j.lanepe.2023.100816},
}
